L01XG03 ixazomib
ATC group of level 5 – chemical substance · in plain English: cancer medicines
This site has the patient leaflet or the SPC of 6 medicines in this group.
- 6 prescription only (POM)
Active substance: Ixazomib – all medicines with this substance, also in combinations.
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L01 Antineoplastic agents 1,025 medicines
- L01X Other antineoplastic agents 225 medicines
- L01XG Proteasome inhibitors, antineoplastic agent 43 medicines
- L01XG03 ixazomib 6 medicines
- L01XG Proteasome inhibitors, antineoplastic agent 43 medicines
- L01X Other antineoplastic agents 225 medicines
- L01 Antineoplastic agents 1,025 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Ixazomib 3 mg hard capsules SPC | Prescription only (POM) |
| Ixazomib 4 mg hard capsules SPC | Prescription only (POM) |
| Ninlaro 2.3 mg hard capsules SPC | Prescription only (POM) |
| Ninlaro 3.0 mg hard capsules | Prescription only (POM) |
| Ninlaro 4 mg hard capsules | Prescription only (POM) |
| Ninlaro 4.0 mg hard capsules | Prescription only (POM) |
Other groups of the same level
- L01XG01 bortezomib 33 medicines
- L01XG02 carfilzomib 4 medicines
Other names of the ATC group
- German: L01XG03 Ixazomib
- German: L01XG03 Ixazomib
- Italian: L01XG03 IXAZOMIB
- Turkish: L01XG03 iksazomib
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L01XG03
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.